SGS owned CDMO to develop and manufacture IBD focused live biotherapeutic for Korean group 14-Apr-2022 By Jane Byrne Quay Pharma, a contract development and manufacturing organization (CDMO), has signed a contract with drug development specialist, Liveome, in relation to the Korean firm’s live biotherapeutic program.